CCN3 is expressed by adipocytes and is believed to contribute to obesity-related inflammation and conditions including type 2 diabetes, sleep apnoea and obesity-induced cardiomyopathy [20, 44, 47, 48]. Here, CCN3 is linked to type 2 diabetes mellitus.